234 related articles for article (PubMed ID: 31093508)
1. pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG.
Wu J; Li S; Li T; Lv X; Zhang M; Zang G; Qi C; Liu YJ; Xu L; Chen J
J Immunol Res; 2019; 2019():1749803. PubMed ID: 31093508
[TBL] [Abstract][Full Text] [Related]
2. Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production.
Berghöfer B; Haley G; Frommer T; Bein G; Hackstein H
J Immunol; 2007 Apr; 178(7):4072-9. PubMed ID: 17371961
[TBL] [Abstract][Full Text] [Related]
3. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human B cell activation by TLR7 and TLR9 agonists.
Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
[TBL] [Abstract][Full Text] [Related]
5. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
6. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation.
Gujer C; Sundling C; Seder RA; Karlsson Hedestam GB; Loré K
Immunology; 2011 Nov; 134(3):257-69. PubMed ID: 21977996
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
8. TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
Wu J; Li S; Yang Y; Zhu S; Zhang M; Qiao Y; Liu YJ; Chen J
Oncotarget; 2017 Feb; 8(7):11708-11718. PubMed ID: 28052019
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
10. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
11. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands.
Ju X; Zenke M; Hart DN; Clark GJ
Blood; 2008 Aug; 112(4):1184-94. PubMed ID: 18535206
[TBL] [Abstract][Full Text] [Related]
12. TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.
Butterfield JSS; Biswas M; Shirley JL; Kumar SRP; Sherman A; Terhorst C; Ling C; Herzog RW
Hum Gene Ther Methods; 2019 Jun; 30(3):81-92. PubMed ID: 31140323
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
[TBL] [Abstract][Full Text] [Related]
14. TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns.
Cardoso EC; Pereira NZ; Mitsunari GE; Oliveira LM; Ruocco RM; Francisco RP; Zugaib M; da Silva Duarte AJ; Sato MN
PLoS One; 2013; 8(6):e67036. PubMed ID: 23826189
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.
Bekeredjian-Ding IB; Wagner M; Hornung V; Giese T; Schnurr M; Endres S; Hartmann G
J Immunol; 2005 Apr; 174(7):4043-50. PubMed ID: 15778362
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells.
Chung NP; Matthews K; Klasse PJ; Sanders RW; Moore JP
J Immunol; 2012 Dec; 189(11):5257-65. PubMed ID: 23100517
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.
Kaushik S; Teque F; Patel M; Fujimura SH; Schmidt B; Levy JA
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):501-10. PubMed ID: 23131038
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B.
Xu N; Yao HP; Lv GC; Chen Z
Inflamm Res; 2012 Sep; 61(9):997-1004. PubMed ID: 22684144
[TBL] [Abstract][Full Text] [Related]
20. Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-alpha and type 1 IFNs after feeding a TLR7/8 ligand.
Yrlid U; Milling SW; Miller JL; Cartland S; Jenkins CD; MacPherson GG
J Immunol; 2006 May; 176(9):5205-12. PubMed ID: 16621985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
